Aptevo insider settles RSUs and withholds shares for tax
Aptevo Therapeutics Inc. reported that Executive Chair Marvin L. White exercised and settled restricted stock units into common stock in July and August 2026.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Aptevo Therapeutics Inc. reported that Executive Chair Marvin L. White exercised and settled restricted stock units into common stock in July and August 2026. On August 6, 2026, 1,666 RSUs granted on August 6, 2025 converted into common shares, with 406 shares withheld at $4.07 per share to satisfy tax withholding obligations. On July 17, 2026, 1 RSU from a July 17, 2024 grant vested and converted into one common share.
Insider Trade Summary
1,667 shares exercised/converted
Exercise
5 txns
Insider
White Marvin L
Role
Executive Chair
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F1, F4 | 1,666 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 1,666 | -- | -- |
| Tax Withholding | Common Stock F2 | 406 | $4.07 | $2K |
| Exercise | Restricted Stock Unit F1, F3 | 1 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 1 | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 0 units (Direct);
Common Stock — 1,261 shares (Direct)
Footnotes (4)
- F1. Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- F2. Represents shares withheld by Issuer to satisfy tax withholding obligations on the vesting of RSUs.
- F3. On July 17, 2024, the reporting person was granted 22,325 (1 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025.
- F4. On August 6, 2025, the reporting person was granted 30,000 (1,666 post-split) RSUs, vesting on the first anniversary of the date of grant.
Key Figures
RSUs converted August 6, 2026: 1,666 shares
Shares withheld for taxes: 406 shares
Tax withholding price: $4.0700 per share
+3 more
6 metrics
RSUs converted August 6, 2026
1,666 shares
Restricted Stock Units granted August 6, 2025 converting into common stock
Shares withheld for taxes
406 shares
Common shares withheld on August 6, 2026 to satisfy tax withholding obligations
Tax withholding price
$4.0700 per share
Value used for shares withheld to cover tax obligations on August 6, 2026
RSUs converted July 17, 2026
1 share
Single RSU from July 17, 2024 grant converting into one common share
July 17, 2024 RSU grant (pre-split)
22,325 RSUs
Grant vesting in three approximately equal annual installments beginning July 17, 2025
August 6, 2025 RSU grant (pre-split)
30,000 RSUs
Grant vesting on the first anniversary of the date of grant
Key Terms
Restricted Stock Unit, tax withholding obligations, post-split, vesting, +1 more
5 terms
Restricted Stock Unit financial
"Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
tax withholding obligations financial
"Represents shares withheld by Issuer to satisfy tax withholding obligations"
post-split financial
"On August 6, 2025, the reporting person was granted 30,000 (1,666 post-split) RSUs"
vesting financial
"RSUs, vesting on the first anniversary of the date of grant"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Executive Chair financial
"White Marvin L serves as Executive Chair of the issuer"
An executive chair is the board chairperson who also takes an active, hands-on role in company management, typically working closely with the CEO and senior team to shape strategy and major decisions. For investors it matters because this blend of oversight and operational power can accelerate strategic moves and provide steady leadership—like a coach who also calls plays—but it can also concentrate authority and create governance or succession risks if too much depends on one person.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Aptevo Therapeutics (APVO) report for Marvin L. White?
Aptevo reported that Executive Chair Marvin L. White exercised RSUs into common stock on July 17 and August 6, 2026. These transactions reflect equity compensation vesting, not open-market buying or selling, and include shares withheld to cover tax obligations.
Were Marvin L. White’s Aptevo (APVO) transactions open-market trades?
No. The reported activity involves RSU exercises and related tax withholding, not open-market purchases or sales. RSUs converted into common stock on a one-for-one basis as they vested according to previously granted equity awards.
What are the key RSU grants referenced in this Aptevo (APVO) Form 4?
The Form 4 references a July 17, 2024 grant of 22,325 RSUs (1 post-split) vesting in three annual installments from July 17, 2025, and an August 6, 2025 grant of 30,000 RSUs (1,666 post-split) vesting on the first anniversary of grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.
